CA-JAKKS-PACIFIC
23.2.2022 17:02:11 CET | Business Wire | Press release
JAKKS Pacific, Inc. (NASDAQ: JAKK) and Disguise, Inc. today announced a new line of toys and costumes launching in Spring 2022 in celebration of Paramount Pictures’ feature film, Sonic the Hedgehog 2 . The new line of merchandise from JAKKS is set to include action figures, playsets, vehicles, plush toys and other collectibles just in time for the film’s international release. Disguise, the costume division of JAKKS Pacific, will also be designing and manufacturing costumes and accessories inspired by characters from Sonic the Hedgehog 2, which will be available to fans this Fall.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220223005098/en/
“JAKKS Pacific is proud to celebrate the release of the new feature film Sonic the Hedgehog 2 with an all-new line of memorabilia commemorating the Blue Blur’s next great adventure,” said Craig Drobis, Senior Vice President of Marketing at JAKKS Pacific, Inc. “With new waves of collectible action figures, cool new playsets, multiple sizes of plush toys, and an all-new radio-controlled Sonic Speed RC, there is something for every Sonic fan and collector.”
“We’ve seen such a great response from fans to the Sonic the Hedgehog products created by JAKKS Pacific, and we’re thrilled to continue working with them to celebrate Sonic the Hedgehog 2,” said Alex Gomez, Director of Licensing & Partnerships for Sonic the Hedgehog. “We hope that fans of the Blue Blur will see the collection as a testament of our appreciation and create memorable Sonic experiences with the products for years to come.”
Through the collaboration, Sonic and JAKKS will launch the following new merchandise items:
- Figurines - An all-new line of 4-inch figures including Dr. Robotnik, Sonic, Tails and Knuckles will be available at retail. These movie-styled figures feature 11 points of articulation for customizable poses, as well as a unique accessory from the film. Made for ages 3 and up, this first wave won’t last long!
- Plush Toys - The 9-inch plush assortment is based on fan favorite characters from the movie. This super soft and cuddly plush comes in Sonic, Tails and Knuckles. Made for ages 3 and up you can find these on shelves and online this Spring. Additionally, a new 13-inch Sonic Plush will also be available exclusively at Target this Spring. This tall plush is super soft and cuddly to the touch. Made for ages 3 and up, the 13-inch Sonic Plush will be available at retail.
- Sonic Speed RC Set - The new Sonic Speed RC lets fans recreate the action from Sonic the Hedgehog 2 . This set includes an iconic ring-shaped controller for forward motion, turns and spinning action. The RC lights up when you select Turbo mode for that extra boost. The 6-inch scale articulated Sonic figure is removable. This awesome RC is made for ages 4 and up and will be available at retail.
-
Costumes and Accessories - Disguise has developed a range of Sonic the Hedgehog 2
costumes and accessories in Toddler, Child and Adult sizes, a dress version of Sonic and a Child accessory kit. All styles are coming to retail in stores and online this fall.
- Toddler - The Sonic the Hedgehog 2 Toddler includes a super soft jumpsuit with white sleeve cuff detailing. Amp up this link with the super cool soft headpiece with Sonic’s signature quills and an attached clear vinyl visor that can be worn up or down!
- Basic Costume - Sonic Basic is a very comfy hooded jumpsuit costume that will have you looking exactly like Sonic! The material is super soft and features a hood with the stiff felt ears and classic Sonic quills.
- Classic Costumes - Sonic and his friend Tails both come in a Classic style version. Both costumes have a comfy hooded jumpsuit of velvet minky material with dimensional ears, embroidered eyes and quills for Sonic and a hair tuft for Tails. Tails features attached dimensional tails at the back!
- Sonic Dress Costume - Disguise also created a dress version of Sonic. This super soft dress with lightning detailing on the skirt comes with a pair of glovettes and a cute headband with Sonic’s signature quills and ears!
- Sonic Deluxe Costume - This super soft jumpsuit with a detachable tail features a detailed Sonic headpiece with attached ears and inflatable quills to give this costume a true movie feel. An included pair of Sonic gloves complete the look!
- Sonic Accessory Kit for Children - The accessory kit comes with a headpiece with ears, inflatable quills, gloves and a pair of red foam shoe covers with lightning bolts! Pair this kit with a blue shirt and jeans for your super easy Sonic look.
- Sonic Adult Unisex Jumpsuit - An extremely soft velvet minky hooded jumpsuit with Sonic’s signature quills and dimensional ears. Put on a pair of red sneakers and you will be ready to speed your way through any party in no time.
- Hooded Jumpsuits - Disguise will also launch 2 Fancy Dress styles in the UK and US for Tails and Sonic. These comfy hooded jumpsuits feature stiff felt ears and classic Sonic quills. Stitched tails at the back give the Tails costume an authentic look.
JAKKS Pacific, Inc. is a leading designer, manufacturer and marketer of toys and consumer products sold throughout the world, headquartered in Santa Monica, California. JAKKS Pacific manages a broad portfolio of licensed and owned I.P. brands and products, with best sellers such as Sonic the Hedgehog action figures, plush and playsets. All products are available online or in retail stores nationwide.
Owned by JAKKS Pacific, Inc., Disguise is a world leader in design and development of inventive and cutting-edge costumes and accessories with distribution across the world. With a dedication to quality and detail, Disguise continues to own the licensed costume space with additional lines rolling out each year. Sonic the Hedgehog 2 brings an exciting cast of characters to the table, making a great fit for dress up products.
About JAKKS Pacific, Inc.:
JAKKS Pacific, Inc. is a leading designer, manufacturer and marketer of toys and consumer products sold throughout the world, with its headquarters in Santa Monica, California. JAKKS Pacific’s popular proprietary brands include: Fly Wheels® , Perfectly Cute® , ReDo Skateboard Co.® , X Power Dozer® , Disguise® , Weee-Do™ and a wide range of entertainment-inspired products featuring premier licensed properties. Through JAKKS Cares, the company’s commitment to philanthropy, JAKKS is helping to make a positive impact on the lives of children. Visit us at www.jakks.com and follow us on Instagram (@jakkstoys), Twitter (@jakkstoys) and Facebook (JAKKS Pacific).
©2022 JAKKS Pacific, Inc. All rights reserved
About Disguise, Inc.:
Since 1987, Disguise has been a leader in the costume industry creating innovative and trend setting costumes and accessories. Based in San Diego, Disguise produces costumes and accessories under many of the world’s leading licensed brands, as well as its own proprietary brands for the nation’s largest retailers including specialty, party and pop-up stores. Disguise designs and manufactures millions of costumes for U.S. and other international markets each year bringing smiles and creating memories for kids and adults alike. To see Disguise’s extensive collection, please visit www.disguise.com and follow us on Instagram (@disguise.costumes), Twitter (@DisguiseInc) and Facebook (Disguise Costumes).
Disguise is a trademark of Disguise, Inc.
About SEGA of America, Inc.:
SEGA of America, Inc. is the American arm of Tokyo, Japan-based SEGA CORPORATION, a worldwide leader in interactive entertainment both inside and outside the home. The company develops, publishes and distributes interactive entertainment software products for a variety of hardware platforms including PC, wireless devices, and those manufactured by Nintendo, Microsoft and Sony Interactive Entertainment Inc. SEGA of America’s website is located at www.sega.com .
About Paramount Pictures Corporation
Paramount Pictures Corporation (PPC), a global producer and distributor of filmed entertainment, is a unit of ViacomCBS (NASDAQ: VIAC; VIACA), a leading content company with prominent and respected film, television and digital entertainment brands. Paramount controls a collection of some of the most powerful brands in filmed entertainment, including Paramount Pictures, Paramount Animation, and Paramount Players. PPC operations also include Paramount Home Entertainment, Paramount Pictures International, Paramount Licensing Inc., and Paramount Studio Group.
© 2022-2023 Paramount Pictures Corporation and Sega of America, Inc. All Rights Reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220223005098/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
